Turnstone Biologics (TSBX) News Today → Read this before you buy AI stocks (From InvestorPlace) (Ad) Free TSBX Stock Alerts $2.87 +0.21 (+7.89%) (As of 05/20/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16, 2024 | markets.businessinsider.comLeerink Partners Reaffirms Their Hold Rating on Turnstone Biologics Corp. (TSBX)May 13, 2024 | investorplace.comTSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024May 13, 2024 | globenewswire.comTurnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsMay 11, 2024 | finance.yahoo.comTurnstone Biologics Corp. (TSBX)May 8, 2024 | globenewswire.comTurnstone Biologics to Present at the 2024 Bank of America Securities Health Care ConferenceApril 18, 2024 | uk.investing.comTurnstone Biologics announces board member resignationApril 16, 2024 | globenewswire.comTurnstone Biologics Appoints William Waddill to its Board of DirectorsApril 12, 2024 | marketbeat.comShort Interest in Turnstone Biologics Corp. (NASDAQ:TSBX) Expands By 42.9%Turnstone Biologics Corp. (NASDAQ:TSBX - Get Free Report) saw a large growth in short interest in March. As of March 31st, there was short interest totalling 625,900 shares, a growth of 42.9% from the March 15th total of 438,000 shares. Based on an average daily volume of 181,300 shares, the short-interest ratio is currently 3.5 days. Approximately 4.7% of the company's shares are short sold.April 12, 2024 | seekingalpha.comTSBX Turnstone Biologics Corp.March 22, 2024 | investorplace.comTSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023March 21, 2024 | globenewswire.comTurnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business HighlightsMarch 7, 2024 | marketbeat.comFmr LLC Buys Shares of 2,830,284 Turnstone Biologics Corp. (NASDAQ:TSBX)Fmr LLC bought a new stake in Turnstone Biologics Corp. (NASDAQ:TSBX - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 2,830,284 shares of the company's stock, valued at approximately $11,1March 2, 2024 | finance.yahoo.comTurnstone Biologics Corp. (NASDAQ:TSBX) institutional investors have had a good week as stock gains 34%March 1, 2024 | marketbeat.comEventide Asset Management LLC Makes New $2.79 Million Investment in Turnstone Biologics Corp. (NASDAQ:TSBX)Eventide Asset Management LLC acquired a new position in shares of Turnstone Biologics Corp. (NASDAQ:TSBX - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 708,317 shares of the company's stock, valued atFebruary 23, 2024 | benzinga.comTurnstone Biologics Stock (NASDAQ:TSBX), Short Interest ReportFebruary 21, 2024 | finance.yahoo.comTurnstone Biologics to Participate in Upcoming Investor ConferencesFebruary 21, 2024 | globenewswire.comTurnstone Biologics to Participate in Upcoming Investor ConferencesFebruary 20, 2024 | finance.yahoo.comTurnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.February 20, 2024 | globenewswire.comTurnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.February 1, 2024 | marketbeat.comTurnstone Biologics (NASDAQ:TSBX) Stock Price Down 9.6%Turnstone Biologics (NASDAQ:TSBX) Shares Down 9.6%January 23, 2024 | msn.comRUM, ENVB and GAME among mid-day moversJanuary 21, 2024 | finance.yahoo.comHere's Why Turnstone Biologics (NASDAQ:TSBX) Must Use Its Cash WiselyJanuary 3, 2024 | seekingalpha.comIPOs In 2023 Disappoint But 2024 Looks BrighterNovember 27, 2023 | finance.yahoo.comTurnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNovember 19, 2023 | realmoney.thestreet.comTurnstone Biologics price target lowered to $15 from $18 at BofANovember 10, 2023 | msn.comTurnstone Biologics GAAP EPS of -$1.00November 10, 2023 | msn.comTurnstone Biologics GAAP EPS of $1.00November 9, 2023 | finance.yahoo.comTurnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsNovember 5, 2023 | morningstar.comTurnstone Biologics Corp TSBXNovember 3, 2023 | finance.yahoo.comTurnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual MeetingSeptember 28, 2023 | finance.yahoo.comTurnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingSeptember 4, 2023 | msn.comTurnstone Biologics GAAP EPS of -$7.56 misses by $6.82September 1, 2023 | finance.yahoo.comTurnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business UpdateAugust 28, 2023 | wsj.comTurnstone Biologics Corp.July 25, 2023 | money.usnews.comTurnstone Biologics CorpJuly 24, 2023 | finance.yahoo.comTurnstone Biologics Corp. Announces Pricing of Upsized Initial Public OfferingJuly 24, 2023 | investing.comTurnstone Biologics Corp (TSBX) Get Turnstone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Next President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump. Click here to see why it will be ______ _________. TSBX Media Mentions By Week TSBX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TSBX News Sentiment▼-1.500.43▲Average Medical News Sentiment TSBX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TSBX Articles This Week▼20▲TSBX Articles Average Week Get Turnstone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AVROBIO News Today Ikena Oncology News Today LENZ Therapeutics News Today Entera Bio News Today Genenta Science News Today Cidara Therapeutics News Today Atara Biotherapeutics News Today Curis News Today CEL-SCI News Today IN8bio News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TSBX) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyThe #1 Crypto for AIWeiss RatingsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
